Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Hepatology. 2012 Jul 6;56(2):523–531. doi: 10.1002/hep.25690

Figure 2.

Figure 2

Change from baseline in weight-for-age z score (WAZ), height-for-age z score (HAZ), and body mass index z score (BMIZ) among subjects treated with peginterferonα2a for 48weeks. Error bars indicate 95% confidence interval. The shaded regions indicate time on peginterferonα2a. Results are from a generalized linear model, adjusted for baseline age and sex.